Recent advances in the management of Crohn's disease. [electronic resource]
Producer: 20081114Description: 709-16 p. digitalISSN:- 1878-3562
- Adalimumab
- Algorithms
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Biological Products -- therapeutic use
- C-Reactive Protein -- drug effects
- Certolizumab Pegol
- Crohn Disease -- diagnosis
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Infliximab
- Laparoscopy -- methods
- Male
- Natalizumab
- Polyethylene Glycols -- therapeutic use
- Prognosis
- Randomized Controlled Trials as Topic
- Risk Assessment
- Sensitivity and Specificity
- Severity of Illness Index
- Survival Rate
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.